KB Home
KBH
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
VSTM Verastem
- 6.4000
- -0.1700-2.59%
Close Mar 26 16:00 ET
- 6.4500
- +0.0500+0.78%
Post 20:01 ET
329.51MMarket Cap-1.75P/E (TTM)
6.6500High6.0100Low697.25KVolume6.5800Open6.5700Pre Close4.40MTurnover2.04%Turnover RatioLossP/E (Static)51.49MShares13.520052wk High-11.41P/B218.38MFloat Cap2.100052wk Low--Dividend TTM34.12MShs Float225.8400Historical High--Div YieldTTM9.74%Amplitude2.1000Historical Low6.3080Avg Price1Lot Size
About Verastem Company
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Company Profile
SymbolVSTM
Company NameVerastem
Listing DateJan 27, 2012
Issue Price10.00
Founded2010
CEOMr. Daniel Paterson
MarketNASDAQ
Employees80
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 500
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-781-292-4200
Websitehttp://www.verastem.com
Company Executives
- Name
- Position
- Salary
- Daniel Paterson
- Director, President and Chief Executive Officer
- 3.63M
- Daniel Calkins
- Chief Financial Officer and Chief Accounting Officer
- 622.56K
- Matthew E. Ros
- Chief Operating Officer
- --
- Brian M. Stuglik, R.Ph.
- Director
- 2.02M
- Robert Gagnon, M.B.A.
- Director
- 64.29K
- Michelle Robertson
- Independent Director
- 84.29K
- John H. Johnson
- Independent Director
- 81.29K
- Anil Kapur
- Independent Director
- 81.75K
- Dr. Karin Tollefson
- Independent Director
- 93.49K
- Dr. Michael Glen Kauffman, M.D.,PhD
- Lead Independent Director
- 124.29K
- Dr. Paul Bunn, M.D.
- Independent Director
- 74.29K
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 89.29K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.